Corrigendum to "Engineering aortic valves via transdifferentiating fibroblasts into valvular endothelial cells without using viruses or iPS cells" [Bioact. Mater. 45 (2025), 181-200].
Where this comes from
- Record sourced from PubMed, PMID 41657948.
- Also identified by DOI 10.1016/j.bioactmat.2025.12.014 and PMC identifier 12874092.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
[This corrects the article DOI: 10.1016/j.bioactmat.2024.11.018.].